These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37333014)

  • 21. Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.
    Huang X; MacIsaac R; Thompson JL; Levin B; Buchsbaum R; Haley EC; Levi C; Campbell B; Bladin C; Parsons M; Muir KW
    Int J Stroke; 2016 Jul; 11(5):534-43. PubMed ID: 27048693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis.
    Thelengana A; Radhakrishnan DM; Prasad M; Kumar A; Prasad K
    Acta Neurol Belg; 2019 Sep; 119(3):359-367. PubMed ID: 29728903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial.
    Li S; Wangqin R; Pan Y; Jin A; Li H; Schwamm LH; Fisher M; Campbell BCV; Parsons MW; Wang Z; Dai H; Li D; Li R; Wang J; Wang D; Wang Y; Zhao X; Li Z; Zheng H; Xiong Y; Meng X; Wang Y
    Stroke Vasc Neurol; 2024 Jan; ():. PubMed ID: 38296586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions: Systematic Review and Meta-Analysis.
    Katsanos AH; Safouris A; Sarraj A; Magoufis G; Leker RR; Khatri P; Cordonnier C; Leys D; Shoamanesh A; Ahmed N; Alexandrov AV; Tsivgoulis G
    Stroke; 2021 Jan; 52(1):308-312. PubMed ID: 33272127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials.
    Bivard A; Huang X; McElduff P; Levi CR; Campbell BC; Cheripelli BK; Kalladka D; Moreton FC; Ford I; Bladin CF; Davis SM; Donnan GA; Muir KW; Parsons MW
    Circulation; 2017 Jan; 135(5):440-448. PubMed ID: 27965285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tenecteplase in acute ischemic stroke: Review of the literature and expert consensus from the French Neurovascular Society.
    Olindo S; Albucher JF; Bejot Y; Berge J; Cordonnier C; Guillon B; Sablot D; Tardy J; Alamowitch S; Sibon I
    Rev Neurol (Paris); 2023 Mar; 179(3):150-160. PubMed ID: 36369068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.
    Kvistad CE; Næss H; Helleberg BH; Idicula T; Hagberg G; Nordby LM; Jenssen KN; Tobro H; Rörholt DM; Kaur K; Eltoft A; Evensen K; Haasz J; Singaravel G; Fromm A; Thomassen L
    Lancet Neurol; 2022 Jun; 21(6):511-519. PubMed ID: 35525250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study.
    Teivane A; Jurjāns K; Vētra J; Grigorjeva J; Kupcs K; Masiliūnas R; Miglāne E
    Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143846
    [No Abstract]   [Full Text] [Related]  

  • 29. Ethnic Differences in the Safety and Efficacy of Tenecteplase Versus Alteplase for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Koh JH; Lim CYJ; Tan LTP; Sia CH; Poh KK; Sharma VK; Yeo LLL; Ho AFW; Wu T; Kong WK; Tan BYQ
    J Stroke; 2024 Sep; 26(3):371-390. PubMed ID: 39266015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenecteplase Versus Alteplase Between 3 and 4.5 Hours in Low National Institutes of Health Stroke Scale.
    Rønning OM; Logallo N; Thommessen B; Tobro H; Novotny V; Kvistad CE; Aamodt AH; Næss H; Waje-Andreassen U; Thomassen L
    Stroke; 2019 Feb; 50(2):498-500. PubMed ID: 30602354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous thrombolysis with 0.9 mg/kg alteplase for acute ischaemic stroke: a network meta-analysis of treatment delay.
    Chen X; Shen Y; Huang C; Geng Y; Yu Y
    Postgrad Med J; 2020 Nov; 96(1141):680-685. PubMed ID: 31857497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tenecteplase versus alteplase after acute ischemic stroke at high age.
    Thommessen B; Næss H; Logallo N; Kvistad CE; Waje-Andreassen U; Ihle-Hansen H; Ihle-Hansen H; Thomassen L; Morten Rønning O
    Int J Stroke; 2021 Apr; 16(3):295-299. PubMed ID: 32631157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Dewey HM; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi CR; Rodrigues E; Zhao H; Salvaris P; Garcia-Esperon C; Bailey P; Rice H; de Villiers L; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Wong AA; Muller C; Coulthard A; Mitchell K; Clouston J; Mahady K; Field D; Ma H; Phan TG; Chong W; Chandra RV; Slater LA; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
    N Engl J Med; 2018 Apr; 378(17):1573-1582. PubMed ID: 29694815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Systematic Review and Meta-analysis.
    Singh A; Singh MP; Gaikwad NR; Kannauje PK
    Ann Neurosci; 2024 Apr; 31(2):132-142. PubMed ID: 38694719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tenecteplase versus alteplase for acute ischaemic stroke in the elderly patients: a post hoc analysis of the TRACE-2 trial.
    Xiong Y; Wang L; Pan Y; Wang M; Schwamm LH; Duan C; Campbell BCV; Li S; Hao M; Wu N; Cao Z; Wu S; Li Z; Wang Y
    Stroke Vasc Neurol; 2024 Jun; ():. PubMed ID: 38858097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review.
    Dundar Y; Hill R; Dickson R; Walley T
    QJM; 2003 Feb; 96(2):103-13. PubMed ID: 12589008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness Comparisons of Drug Therapy on Chronic Subdural Hematoma Recurrence: A Bayesian Network Meta-Analysis and Systematic Review.
    Yu W; Chen W; Jiang Y; Ma M; Zhang W; Zhang X; Cheng Y
    Front Pharmacol; 2022; 13():845386. PubMed ID: 35401183
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis.
    Li HY; Wang YB; Ren XY; Wang J; Wang HS; Jin YH
    Pharmacology; 2023; 108(2):111-126. PubMed ID: 36603558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
    Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the efficacy of acupuncture-related Therapies for post-stroke motor aphasia: A Bayesian network meta-analysis.
    Feng S; Tang M; Huang G; Wang J; Lv Y; He S; Liu D; Gu L
    Front Neurol; 2022; 13():992079. PubMed ID: 36619913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.